AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

Each Tablet Contains:Ciprofloxacin Hydrochloride Equivalent To Ciprofloxacin 500,0 Mg

10 registrations across 1 African market— 10 active

Markets with Each Tablet Contains:Ciprofloxacin Hydrochloride Equivalent To Ciprofloxacin 500,0 Mg

Recent registrations

Brand / ProductMarketHolderStatusExpires
BIOFLOXX 500🇿🇦South AfricaArya Pharma (Pty) LtdactiveJan 1900
CIPROFLOXACIN ACTOR 500🇿🇦South AfricaCipla Medpro (Pty) LtdactiveJan 1900
CIFLOC 500🇿🇦South AfricaDr ReddyÆs Laboratories (Pty) LtdactiveJan 1900
GULF CIPROFLOXACIN 500🇿🇦South AfricaGulf Drug Company (Pty) LtdactiveJan 1900
COLIPRID 500 mg TABLETS🇿🇦South AfricaAurogen South Africa (Pty) LtdactiveJan 1900
LOXIP 500 mg🇿🇦South AfricaAurogen South Africa (Pty) LtdactiveJan 1900
CIPROFLOXACIN 500 MG AUSTELL🇿🇦South AfricaAustell Pharmaceuticals (Pty) LtdactiveJan 1900
CIPROFLOXACIN UNICORN 500🇿🇦South AfricaAscendis Pharma (Pty) LtdactiveJan 1900
BIO-CIPROFLOXACIN 500🇿🇦South AfricaBiotech Laboratories (Pty) LtdactiveJan 1900
PROFLOXIN 500🇿🇦South AfricaDezzo Trading 392 (Pty) LtdactiveJan 1900

Each Tablet Contains:Ciprofloxacin Hydrochloride Equivalent To Ciprofloxacin 500,0 Mg in Africa — Regulatory Overview

Each Tablet Contains:Ciprofloxacin Hydrochloride Equivalent To Ciprofloxacin 500,0 Mg is registered across 1 African markets with 10 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including South Africa. AfricaRegulatory refreshes this data daily from official government sources.

Of the 10 registrations, 10 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.